跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAGLIPTINA CINFAMED 50 MG COMPRIMIDO RECUBIERTO CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SITAGLIPTINA CINFAMED 50 MG COMPRIMIDO RECUBIERTO CON PELICULA EFG
Approved
STANDARD
SITAGLIPTINA CINFAMED 50 MG COMPRIMIDO RECUBIERTO CON PELICULA EFG
Laboratorios Cinfa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 22, 2021
Approval ID
c7464f613a3ed257
Company
Laboratorios Cinfa S.A.
Type
Standard
Approval Details
Approval Id
c7464f613a3ed257
Drug Cima Aemps Name
SITAGLIPTINA CINFAMED 50 MG COMPRIMIDO RECUBIERTO CON PELICULA EFG
Register Number
86324
Holder Company Name
Laboratorios Cinfa S.A.
Marketing Company Name
Laboratorios Cinfa S.A.
Authorization Date
2021-10-22
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Cinfa S.A.
Active Ingredients
SITAGLIPTINA HIDROCLORURO
54,47 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 22, 2021
Approval ID
c7464f613a3ed257
Type
Standard
Back to CIMA-AEMPS Approvals